Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT05005793
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Kidney Transplant; Complications
- Metabolic Acidosis
- Vascular Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sodium bicarbonate — DRUGOral sodium bicarbonate at 0.5 mEq/kg-lean body weight/day
- Placebo — DRUGPlacebo at 0.5 mEq/kg-lean body weight/day
Study Details
Lower serum bicarbonate levels, even within the normal laboratory range, in kidney transplant recipients (KTRs) are associated with an increased risk of graft loss, cardiovascular events and mortality. Because acid retention is common in KTRs, it is plausible that alkali therapy in KTRs may also result in improved vascular and graft function. The investigators will perform a randomized, double-blinded, placebo-controlled, 12 month study in 120 KTRs to examine the effect of sodium bicarbonate therapy on surrogate markers of CVD and graft function. The overall hypothesis is that treatment with bicarbonate will improve indicators of vascular and graft function in KTRs by decreasing complement activation.
Key Dates
- Start date
- Dec 1, 2021
- Status verified
- May 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Sodium bicarbonateOral sodium bicarbonate at a dose of 0.5 mEq/kg-lean body weight/day
- Placebo Comparator: PlaceboOral placebo at a dose of 0.5 mEq/kg-lean body weight/day
Primary Outcome Measure
Change in Brachial artery flow mediated dilation at 12 months [ Time Frame: Baseline and 12 months ]
Central Contacts
- Jessica Kendrick, MD MPH3037244837
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado | Aurora | Colorado | 80045 |
Find similar trials in Aurora, CO
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant RecipientsPHASE4 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Global Paradise System US Post Approval StudyRecruiting · ReCor Medical, Inc. · Sacramento, California
- Natural History of Stroke: Cause and DevelopmentRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Washington D.C., District of Columbia